Product NDC: | 67457-211 |
Proprietary Name: | Fomepizole |
Non Proprietary Name: | Fomepizole |
Active Ingredient(s): | 1 g/mL & nbsp; Fomepizole |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67457-211 |
Labeler Name: | Mylan Institutional LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078639 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121009 |
Package NDC: | 67457-211-02 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (67457-211-02) > 1.5 mL in 1 VIAL, GLASS |
NDC Code | 67457-211-02 |
Proprietary Name | Fomepizole |
Package Description | 1 VIAL, GLASS in 1 CARTON (67457-211-02) > 1.5 mL in 1 VIAL, GLASS |
Product NDC | 67457-211 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fomepizole |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20121009 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Institutional LLC |
Substance Name | FOMEPIZOLE |
Strength Number | 1 |
Strength Unit | g/mL |
Pharmaceutical Classes | Antidote [EPC] |